Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
1.
Korean Journal of Family Medicine ; : 40-42, 2017.
Artículo en Inglés | WPRIM | ID: wpr-109990

RESUMEN

Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.


Asunto(s)
Adulto , Femenino , Humanos , Embarazo , Embarazo , Amenorrea , Trastornos de Ansiedad , Citalopram , Trastorno Depresivo Mayor , Hiperprolactinemia , Pruebas de Embarazo , Pruebas Inmunológicas de Embarazo , Serotonina , Inhibidores Selectivos de la Recaptación de Serotonina , United States Food and Drug Administration
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA